Valuation: Enovis Corporation

Capitalization 1.83B 1.57B 1.47B 1.34B 2.5B 157B 2.8B 17.38B 6.68B 72.3B 6.85B 6.7B 264B P/E ratio 2025 *
-22.7x
P/E ratio 2026 * -232x
Enterprise value 2.99B 2.57B 2.4B 2.19B 4.09B 257B 4.59B 28.45B 10.93B 118B 11.21B 10.97B 433B EV / Sales 2025 *
1.34x
EV / Sales 2026 * 1.19x
Free-Float
97.34%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+6.68%
1 week+3.50%
Current month+2.11%
1 month+1.27%
3 months-20.10%
6 months-27.28%
Current year-27.16%
More quotes
1 week 28.83
Extreme 28.83
31.99
1 month 28.83
Extreme 28.83
34
Current year 28.83
Extreme 28.83
49.38
1 year 28.83
Extreme 28.83
49.83
3 years 28.83
Extreme 28.83
66.71
5 years 28.83
Extreme 28.83
164.01
10 years 28.83
Extreme 28.83
164.01
More quotes
Manager TitleAgeSince
Chief Executive Officer 60 11/05/2025
Director of Finance/CFO 46 31/12/2022
Investor Relations Contact - 31/07/2023
Director TitleAgeSince
Director/Board Member 54 12/05/2008
Director/Board Member 66 20/09/2010
Chairman 63 20/05/2025
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+6.68%+3.50%-29.01%-45.14% 1.71B
+1.93%+3.51%+13.98%+89.04% 145B
+1.20%+1.39%+9.67%-6.22% 12.75B
+1.17%-0.30%-1.65%-57.18% 7.16B
+3.51%+0.39%-10.52%+112.02% 5.53B
+1.98%+4.17%-2.03%-33.15% 3.83B
+0.75%-.--%+4.81%+21.19% 3.63B
+0.42%-1.52%+38.80%-11.46% 2.01B
-0.37%-1.12%+1.27%-15.46% 1.97B
+0.92%-1.30%-12.51%-33.89% 1.47B
Average +1.82%+1.12%+1.28%+1.97% 18.5B
Weighted average by Cap. +1.87%+2.89%+11.36%+69.21%
See all sector performances

Financials

2025 *2026 *
Net sales 2.24B 1.92B 1.8B 1.64B 3.06B 192B 3.43B 21.29B 8.18B 88.56B 8.39B 8.21B 324B 2.38B 2.04B 1.91B 1.74B 3.26B 204B 3.65B 22.63B 8.7B 94.14B 8.92B 8.73B 344B
Net income -83.21M -71.55M -66.94M -61.06M -114M -7.15B -128M -792M -304M -3.3B -312M -306M -12.04B -13.75M -11.82M -11.06M -10.09M -18.84M -1.18B -21.12M -131M -50.3M -545M -51.58M -50.49M -1.99B
Net Debt 1.16B 1B 935M 853M 1.59B 99.94B 1.79B 11.07B 4.25B 46.05B 4.36B 4.27B 168B 1.01B 871M 815M 743M 1.39B 87.08B 1.56B 9.64B 3.71B 40.12B 3.8B 3.72B 147B
More financial data * Estimated data
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.
Employees
7,367
More about the company
Date Price Change Volume
24/06/25 31.96 $ +6.68% 1,299,479
23/06/25 29.96 $ -0.50% 1,298,718
20/06/25 30.11 $ -1.79% 1,107,516
18/06/25 30.66 $ -0.71% 1,308,288
17/06/25 30.88 $ -4.25% 1,307,153

Delayed Quote Nyse, June 24, 2025 at 09:00 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
31.96USD
Average target price
56.50USD
Spread / Average Target
+76.78%
Consensus

Quarterly revenue - Rate of surprise